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In the present study, we investigated the seroprevalence of E. histolytica at a voluntary 96 counselling and testing (VCT) centre in Tokyo, in comparison with the prevalence of other 97 sexually transmitted infections (STIs). In addition, we discuss future strategies for the 98 epidemiologic control of sexually transmitted E. histolytica infection.
METHODS
100 Setting 101 Tokyo, the capital city of Japan, is located on the Pacific on the eastern coast of Honshu, 102 the largest of the four main islands comprising Japan. According to the national surveillance 103 system, the annual number of HIV tests performed and the incidence rates of HIV infection are 104 higher in Tokyo than those of other prefectures [11] . The Tokyo Metropolitan Minami Shinjuku 105 Testing -Counselling Centre is the largest HIV testing centre in Tokyo, and it is very close to a 106 town in Shinjuku with a large population of men who have sex with men (MSM) [12] . Because 107 there are more MSM who visit this centre to undergo testing for HIV and other STIs, the 108 incidence rate of HIV infection at this centre is higher than that of other public health centres in 109 138 After a 15-minute incubation, 100 L of stop solution was applied to the plates, and absorbance 139 of the specimen was then read at 450/620 nm using a spectrometer. 155 histolytica was 2.64%; this was significantly higher than that for HIV-1 (0.34%) and the 156 comparable level as that for syphilis by RPR (2.11%) (Fig 2A) . The positive rate of urinary TMA 157 for C. trachomatis (4.59%) was higher than the seropositivity for E. histolytica; however, urinary 158 TMA testing for C. trachomatis and N. gonorrhoeae was only carried out in 69.0% (1,437/2,083) 159 of clients, i.e., those who were willing to undergo TMA testing. These results suggest that E. 160 histolytica is a more common STI than HIV-1 in Tokyo and is at a level comparable to that of 161 syphilis infection. Interestingly, all individuals who were seropositive for E. histolytica were 162 seronegative for HIV-1 ( Fig 2B) . Furthermore, the seropositive rate for E. histolytica was 163 significantly higher among people who were seropositive for syphilis infection (by both RPR and 164 TPHA) than among those who were seronegative for syphilis; no significant differences in E. 
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The present study has some limitations that should be considered. First, this preliminary 284 investigation was a cross-sectional study of anonymous clients at a VCT centre. We could not 285 assess risk behaviour or sexual behaviour with respect to seropositivity for E. histolytica owing 286 to a lack of detailed data on the characteristics of clients. In addition, the study periods were 2 287 months apart owing to the availability of data for not only HIV-1 but also other STIs (serum tests 288 for syphilis and urine tests for chlamydia and gonorrhoea). We could not exclude the possibility 289 of selection bias of clients, such as those who undergo repeat testing. In future, intensifying STI 290 screening services at VCT centres should be considered, for epidemiological control of these 291 prevalent STIs in Japan. Second, anti-E. histolytica antibody was screened using stored serum. 
